Clinical Research Directory
Browse clinical research sites, groups, and studies.
Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Summary
Radiochemotherapy is the standard treatment for neoplasms of the anal canal with excellent rates of local control and preservation of the anal sphincter. However, patients may experience a deterioration of quality of life related to sequelae of the treatment particularly at intestinal, anal sphincter and sexual level. Few studies to date have documented patient-reported outcomes (PROs) in this area. The aim of this observational study is to verify the quality of life (QOL) of the patients by means of self-completed questionnaires.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2024-03-28
Completion Date
2031-01-31
Last Updated
2025-08-26
Healthy Volunteers
No
Conditions
Locations (1)
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Lazio, Italy